<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024</dc:title><dc:creator>Biester,	Torben	(Avtor)
	</dc:creator><dc:creator>Berget,	Cari	(Avtor)
	</dc:creator><dc:creator>Boughton,	Charlotte	(Avtor)
	</dc:creator><dc:creator>Cudizio,	Laura	(Avtor)
	</dc:creator><dc:creator>Ekhlaspour,	Laya	(Avtor)
	</dc:creator><dc:creator>Hilliard,	Marisa E.	(Avtor)
	</dc:creator><dc:creator>Reddy,	Leenatha	(Avtor)
	</dc:creator><dc:creator>Dovč,	Klemen	(Avtor)
	</dc:creator><dc:subject>pump</dc:subject><dc:subject>automated insulin delivery</dc:subject><dc:subject>children</dc:subject><dc:subject>diabetes mellitus</dc:subject><dc:subject>adolescent</dc:subject><dc:subject>blood glucose</dc:subject><dc:description>The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and summarizes recent advances in the technology behind insulin administration, with special emphasis on insulin pump therapy, especially on glucose-responsive integrated technology that is feasible with the use of automated insulin delivery (AID) systems in children and adolescents.</dc:description><dc:date>2025</dc:date><dc:date>2026-02-24 15:15:16</dc:date><dc:type>Neznano</dc:type><dc:identifier>27783</dc:identifier><dc:identifier>UDK: 616.379</dc:identifier><dc:identifier>ISSN pri članku: 1663-2826</dc:identifier><dc:identifier>DOI: 10.1159/000543034</dc:identifier><dc:identifier>COBISS_ID: 254572803</dc:identifier><dc:language>sl</dc:language></metadata>
